HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Nishi Selected Research

prolylleucine

11/2011Pro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patients.
9/2004Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahiro Nishi Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
01/2016 - 08/2002
5Neoplasms (Cancer)
11/2021 - 01/2017
5Cardiomyopathies (Cardiomyopathy)
11/2021 - 12/2015
5Immunoglobulin G4-Related Disease
07/2021 - 01/2013
4Obesity
01/2022 - 02/2004
4Diabetes Mellitus
04/2021 - 05/2013
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2018 - 01/2006
3Insulinoma
07/2018 - 01/2006
2Hypoxia (Hypoxemia)
01/2022 - 01/2016
2Infarction (Infarctions)
01/2022 - 01/2019
2Cardiotoxicity
11/2021 - 01/2020
2Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
04/2021 - 06/2017
2Cardiomegaly (Heart Hypertrophy)
01/2019 - 01/2016
2Pituitary Neoplasms (Pituitary Adenoma)
09/2017 - 01/2017
2Graves Disease (Basedow Disease)
01/2017 - 04/2014
2Thyroiditis
01/2015 - 01/2013
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2011 - 04/2006
2Polyneuropathies (Polyneuropathy)
11/2011 - 07/2006
2Mason-Type Diabetes
04/2011 - 08/2002
2Diabetic Neuropathies (Diabetic Neuropathy)
01/2010 - 04/2006
2Diabetic Nephropathies (Diabetic Nephropathy)
07/2009 - 01/2008
1Inflammation (Inflammations)
10/2022
1Morbid Obesity
10/2022
1Lymphoma (Lymphomas)
03/2022
1Hypopituitarism (Sheehan's Syndrome)
03/2022
1Hypothermia
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Reperfusion Injury
01/2022
1Combined Pituitary Hormone Deficiency
07/2021
1Autoimmune Hypophysitis
07/2021
1Ketosis
04/2021
1Empyema
04/2021
1Hypocalcemia
03/2021
1Vitamin D Deficiency
03/2021
1Pheochromocytoma
06/2020
1Headache (Headaches)
06/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Adrenocorticotropic hormone deficiency
12/2019
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Melanoma (Melanoma, Malignant)
07/2018
1Diabetes Complications
05/2018
1Hypothyroidism
05/2018
1Thyroid Diseases (Thyroid Disease)
05/2018
1ST Elevation Myocardial Infarction
01/2018

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
06/2020 - 02/2006
6Glucose (Dextrose)FDA LinkGeneric
04/2021 - 02/2004
5Insulin (Novolin)FDA Link
04/2021 - 02/2004
5Messenger RNA (mRNA)IBA
01/2017 - 12/2004
4Immunoglobulin G (IgG)IBA
01/2016 - 01/2013
3Adrenocorticotropic Hormone (ACTH)FDA Link
09/2017 - 01/2014
3Transcription Factors (Transcription Factor)IBA
01/2017 - 08/2002
3alpha-TocopherolFDA Link
08/2008 - 12/2004
2Prednisolone (Predate)FDA LinkGeneric
07/2021 - 09/2004
2SteroidsIBA
07/2021 - 01/2016
2CalciumIBA
03/2021 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 09/2017
2AntigensIBA
12/2019 - 01/2017
2Thyroid HormonesIBA
05/2018 - 01/2016
2Octreotide (Sandostatin)FDA LinkGeneric
06/2017 - 01/2017
2Caveolin 3IBA
01/2016 - 12/2015
2Immunoglobulins (Immunoglobulin)IBA
01/2015 - 04/2014
2prolyl-proline (Pro-Pro)IBA
11/2011 - 09/2004
2prolylleucineIBA
11/2011 - 09/2004
2Glutathione Peroxidase GPX1IBA
11/2011 - 12/2004
2AntioxidantsIBA
06/2011 - 02/2006
2GhrelinIBA
04/2010 - 01/2006
2NAD (NADH)IBA
01/2010 - 07/2006
1LeptinIBA
10/2022
1AdiponectinIBA
10/2022
1TroponinIBA
01/2022
12-methylthiazolineIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Immune Checkpoint InhibitorsIBA
11/2021
1AnthracyclinesIBA
11/2021
1Chimeric Antigen ReceptorsIBA
11/2021
1Monoclonal AntibodiesIBA
11/2021
1empagliflozinIBA
04/2021
1SodiumIBA
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2021
1Calcium-Sensing ReceptorsIBA
03/2021
1CatecholaminesIBA
06/2020
1RNA (Ribonucleic Acid)IBA
06/2020
1Endoplasmic Reticulum Chaperone BiPIBA
06/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Caspase 3 (Caspase-3)IBA
01/2019
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2019
1Early Growth Response Protein 1IBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1NivolumabIBA
07/2018
1AntibodiesIBA
07/2018
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2018
1Vitamin DFDA LinkGeneric
01/2018

Therapy/Procedure

6Therapeutics
01/2022 - 01/2016
2Stents
10/2016 - 01/2016
1Gastrectomy
10/2022
1Drug Therapy (Chemotherapy)
03/2022
1Induced Hypothermia
01/2022
1Immunotherapy
11/2021
1Adrenalectomy
06/2020